# Drug Enforcement Administration, Diversion Control Division (DEA)

**In short:** DEA's Diversion Control Division registers practitioners and others who handle controlled substances under the Controlled Substances Act; a practitioner with practice locations in more than one state needs a separate DEA registration in each. Registrants must report a theft or significant loss within one business day of discovery, and DEA can move to suspend or revoke a registration through an Order to Show Cause or, where there is imminent danger to public health or safety, an Immediate Suspension Order. The fourth temporary extension of the COVID-19 telemedicine flexibilities lets registered practitioners prescribe schedule II to V controlled medications by telemedicine without a prior in-person evaluation through December 31, 2026, while DEA's special registration rule remains a proposal.

Federal agency · Healthcare. Published November 14, 2026. Last reviewed November 14, 2026. Official site: <https://www.deadiversion.usdoj.gov/>.

License: CC BY 4.0. Underlying government texts are public domain or under their own terms. <https://creativecommons.org/licenses/by/4.0/>. Attribution: "Moraph Insights", <https://insights.moraph.com/regulators/dea-diversion>.

Each point ends with the number of its source in "Sources". Points were checked on November 14, 2026 unless the point gives another date. Data: <https://insights.moraph.com/regulators/dea-diversion.json> (JSON).

## Remit

- The Diversion Control Division's site takes online applications to obtain or renew a DEA registration and offers Ask REGIS, a chatbot released in beta, for general questions about DEA registration requirements and processes. [1]
- Its home page notes that a waiver registration is no longer required to treat patients with opioid use disorder, and its registration menu links to the MATE Act training requirements. [1]
- Under 21 U.S.C. 824(a) DEA may suspend or revoke a registration on findings that include material falsification of the application or an act that would make registration inconsistent with the public interest. [2]

## Who it supervises

- Only persons actually engaged in handling controlled substances, such as dispensing, must hold a registration (21 CFR 1301.11(a)); a practitioner must also have authority under the laws of the state where it practices to dispense controlled substances. [3]
- A practitioner with a professional practice location in more than one state must obtain a separate DEA registration in each of those states; a DEA registration based on a state license cannot authorize controlled substance dispensing outside that state. [3]

## How it examines

- A registrant must notify the DEA Field Division Office in its area, in writing, of any theft or significant loss of controlled substances within one business day of discovery, and file a complete DEA Form 106 within 45 days (21 CFR 1301.76(b)). [4]
- Before denying, revoking or suspending a registration, DEA serves an Order to Show Cause; the registrant may submit a corrective action plan, which DEA reviews to decide whether to discontinue or defer the proceedings (21 U.S.C. 824(c)). [2]

## Technology and security guidance

- DEA's telemedicine page says it is drafting updated regulations for telemedicine; it held public listening sessions on September 12 and 13, 2023, receiving comments from 58 practitioners, experts, advocates, patients and others. [5]

## Recent rules

- Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (DEA with HHS, published December 31, 2025): effective January 1, 2026 through December 31, 2026, DEA-registered practitioners may prescribe schedule II to V controlled substances by telemedicine to a patient they have not evaluated in person, if the rule's conditions are met. [6]
- The extension cites the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, with the telemedicine definition at 21 U.S.C. 802(54) and the in-person evaluation requirement at 21 U.S.C. 829(e). [6]
- Special Registrations for Telemedicine and Limited State Telemedicine Registrations (proposed January 17, 2025) would establish a special registration framework with three types of special registration and heightened prescription, recordkeeping and reporting requirements. Proposed, as checked on 2026-11-14. [7]
- The final rules on buprenorphine treatment via telemedicine and on continuity of care via telemedicine for Veterans Affairs patients, first published January 17, 2025: the extension published December 31, 2025 states that they go into effect on December 31, 2025. [6]

## Enforcement

What the regulator's own pages say about its enforcement. Not a count or a pattern of actions.

- DEA calls Orders to Show Cause and Immediate Suspension Orders its administrative actions; it may issue them when it finds a registrant has violated the Controlled Substances Act. [2]
- An Immediate Suspension Order under 21 U.S.C. 824(d) is used where there is imminent danger to public health or safety, meaning a substantial likelihood of an immediate threat of death, serious bodily harm or abuse of a controlled substance. [2]
- The Division's What's New page posts Decision and Order documents in registrant cases, the latest dated November 12, 2026 as checked on 2026-11-14. [8]

## Official channels

- Registration: <https://www.deadiversion.usdoj.gov/drugreg/registration.html>
- Telemedicine: <https://www.deadiversion.usdoj.gov/Telemedicine.html>
- Administrative actions: <https://www.deadiversion.usdoj.gov/administrative_actions.html>
- What's New (decisions, orders and rules): <https://www.deadiversion.usdoj.gov/new.html>

## Sources

1. Drug Enforcement Administration, Diversion Control Division. DEA Diversion Control Division (home page). <https://www.deadiversion.usdoj.gov/> Checked November 14, 2026.
2. Drug Enforcement Administration, Diversion Control Division. Administrative Actions. <https://www.deadiversion.usdoj.gov/administrative_actions.html> Checked November 14, 2026.
3. Drug Enforcement Administration, Diversion Control Division. Registration Q&A. <https://www.deadiversion.usdoj.gov/faq/registration-faq.html> Checked November 14, 2026.
4. Office of the Federal Register (eCFR). 21 CFR 1301.76, Other security controls for practitioners (eCFR). <https://www.ecfr.gov/current/title-21/section-1301.76> Checked November 14, 2026.
5. Drug Enforcement Administration, Diversion Control Division. Telemedicine. <https://www.deadiversion.usdoj.gov/Telemedicine.html> Checked November 14, 2026.
6. Drug Enforcement Administration and Department of Health and Human Services (Federal Register). Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, Federal Register document 2025-24123 (December 31, 2025; govinfo). <https://www.govinfo.gov/content/pkg/FR-2025-12-31/html/2025-24123.htm> Checked November 14, 2026.
7. Drug Enforcement Administration (Federal Register). Special Registrations for Telemedicine and Limited State Telemedicine Registrations, proposed rule, document 2025-01099 (January 17, 2025; abstract opened through the Federal Register API). <https://www.federalregister.gov/documents/2025/01/17/2025-01099/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations> Checked November 14, 2026.
8. Drug Enforcement Administration, Diversion Control Division. What's New. <https://www.deadiversion.usdoj.gov/new.html> Checked November 14, 2026.

Last reviewed: November 14, 2026
Canonical URL: <https://insights.moraph.com/regulators/dea-diversion>
Publisher: Moraph Insights
